Uganda Virus Research Institute

Name

Uganda Virus Research Institute

Legal name

Uganda Virus Research Institute

Website

https://uvri.go.ug

Company type

Private

Founded year

1936

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Uganda Virus Research Institute (UVRI) is a government health research institution under Uganda's Ministry of Health, founded in 1936 in Entebbe. It conducts virology research, reference diagnostics, genomic sequencing, epidemiological surveillance, and training across Uganda and East Africa.

Ownership category

akta.pro rank

Product category

Public Health Research and Viral Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Sexual Health & STI/HIV Prevention Health Departments (HLAJAAAL)

Keywords

• Viral disease research
• Diagnostic laboratory services
• Genomic sequencing
• Epidemiological surveillance
• Public health research

Headquarters

HQ city

Entebbe

HQ country

Uganda

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Government Funding: UVRI is a government institution under the Ministry of Health, Uganda, funded primarily by the Government of Uganda through the Ministry of Health and various government health research programs.
2. Research Grants and International Partnerships: UVRI receives funding from international organizations including Wellcome Trust, UK Aid, NIH, EDCTP, CEPI, and other global health research funders for specific research projects and capacity building programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

UVRI is a government health research institute that provides clinical and research diagnostic testing for viral pathogens (HIV, Ebola, arboviral diseases, respiratory viruses) using PCR/RT-PCR, serology, ELISA, rapid antigen tests, and culture/isolation. It also delivers next-generation genomic sequencing (whole genome, metagenomics, phylogenetics, variant analysis), BSL-2 and BSL-3 certified reference laboratory services, epidemiological investigations, disease surveillance and outbreak response, and capacity building through training, fellowships, and collaborative research programs.

Product overview

UVRI operates as a government health research institute providing a comprehensive suite of laboratory and research services. The institute offers diagnostic services (PCR/RT-PCR, serology, rapid antigen tests, culture/isolation), genomic sequencing (whole genome, metagenomics, phylogenetics), BSL-2/BSL-3 reference laboratory services, and epidemiology & surveillance capabilities. UVRI also provides capacity building through training programs and fellowships, and supports research collaboration via clinical trials and joint grants. The institute runs multiple research projects including COVID-19 national reference laboratory services, the Technology & Innovation Support Centre (TISC), INVONAT for natural therapeutics, WORMVACS2.0 for helminth vaccine research, EDCTP-EACCR2 for clinical research networks, and maintains a clinical unit providing preventive and curative health services.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Services
• Genomic Sequencing
• Reference Laboratory Services
• Epidemiology and Surveillance
• Capacity Building Programs
• Research Collaboration
• UVRI Clinic (Clinical Unit for Research)

Quantifiable outcome

• Discovered over 40 viruses globally including Zika and West Nile viruses
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

18 partnerships are on record, tiered major and core.

• Uganda Registration Services Bureau (URSB)majorStrategic or Co-development Partner · 28 February 2026Partnership to establish the 38th Technology & Innovation Support Centre (TISC) at UVRI, a WIPO global initiative providing patent databases and intellectual property support for researchers and innovators.
• Target Malaria ConsortiumcoreStrategic or Co-development Partner · 1 January 2012UVRI is the Uganda collaborating partner in Target Malaria, a not-for-profit research consortium developing genetic technologies to modify mosquitoes and reduce malaria transmission using gene drive technology.
• Makerere UniversitycoreStrategic or Co-development PartnerLong-standing partnership for joint research programs, training, and academic collaboration. UVRI and Makerere University jointly operate the MUII (Makerere University – UVRI Centre of Excellence for Infection & Immunity Research and Training) program.
• Ministry of Health UgandacoreStrategic or Co-development PartnerUVRI operates as a government health research hub under the Ministry of Health, providing national reference laboratory services, disease surveillance, and outbreak response support to the government.
• Imperial College LondoncoreStrategic or Co-development PartnerCollaboration on vaccine research, genetic technologies, and research capacity building. Imperial College leads the Target Malaria consortium with UVRI as the Uganda partner.
• London School of Hygiene and Tropical MedicinecoreStrategic or Co-development PartnerLong-standing research partnership in HIV research, vaccine studies, and global health. LSHTM is a partner in multiple UVRI research consortia including THRiVE-2, VAnguard, and EDCTP-EACCR.
• University of CambridgecoreStrategic or Co-development PartnerCollaborates on immunology research, maternal health studies, and fellowship programs. Cambridge is a partner in THRiVE-2 consortium and provides mentorship for PhD fellows.
• Oxford UniversitycoreStrategic or Co-development PartnerPartner in vaccine research, VAnguard project, and Target Malaria consortium. Collaborates on social and biological factors affecting vaccine impact in African communities.
• Johns Hopkins UniversitymajorStrategic or Co-development PartnerCollaborates on HIV research and other infectious disease studies.
• Joint Clinical Research Centre (JCRC)majorStrategic or Co-development PartnerLocal partner in Uganda for clinical research collaboration.
• Mbarara University Science and TechnologymajorStrategic or Co-development PartnerRegional university partner for research collaboration in southwestern Uganda.
• Infectious Diseases Institute (IDI) - MakereremajorStrategic or Co-development PartnerCollaborates on HIV research, training, and infectious disease studies.
• Rakai Health Sciences ProgrammajorStrategic or Co-development PartnerLong-standing partnership on HIV research, epidemiological studies, and community health research in the Rakai district.
• World Health Organization (WHO)coreStrategic or Co-development PartnerUVRI is designated as a WHO Collaborating Centre for viral research and collaborates on outbreak response, disease surveillance, and global health security initiatives.
• Coalition for Epidemic Preparedness Innovations (CEPI)coreStrategic or Co-development PartnerUVRI is part of CEPI's Centralized Clinical Laboratory Network, conducting standardized immunological testing and vaccine immunogenicity assessments for emerging infectious diseases.
• Ministry of Science and Technology Innovations - Office of the President (STI-OP)coreStrategic or Co-development PartnerINVONAT Program funded by Government of Uganda through STI-OP under Pathogen Economy/PRESIDE Projects to study natural therapeutics.
• Medical Research Council (MRC) UgandacoreStrategic or Co-development PartnerLong-standing partnership through MRC/UVRI & LSHTM Uganda Research Unit on AIDS research and other infectious disease studies.
• KEMRI | Wellcome Trust Research ProgrammecoreStrategic or Co-development PartnerKenyan partner in VAnguard project and other collaborative research programs.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Kenya Medical Research Institute (KEMRI): Kenya's national medical research institute and UVRI's most direct East African counterpart. KEMRI operates parallel national reference laboratory functions, BSL facilities, and disease surveillance programs, and collaborates with UVRI on regional consortiums (e.g., VAnguard), making them direct peers in mandate and capability.
• MRC Unit The Gambia at LSHTM: MRC/LSHTM's West African research unit conducting infectious disease epidemiology, vaccine trials, and laboratory science. It shares UVRI's MRC/LSHTM partnership lineage, tropical disease research focus, and clinical trial laboratory support role, making it a structural peer.
• Bernhard Nocht Institute for Tropical Medicine: Germany's federal reference center for tropical viral diseases including Ebola, Lassa, and arboviruses. It is comparable to UVRI in its mandate as a national/regional reference lab for viral tropical diseases and operates similar BSL-3 + genomic sequencing workflows.
• Institut Pasteur de Dakar: Senegal's Pasteur Institute branch, recently designated as a regional hub for vaccine manufacturing in Africa. It shares UVRI's role as a Pasteur-network reference laboratory for virology and is rapidly scaling BSL-3 and genomic capacity, making it a closely matched peer in West Africa.
• National Institute for Communicable Diseases (South Africa): South Africa's national public health reference laboratory providing viral diagnostics, genomic surveillance, and outbreak response. NICD operates with a broader pathogen scope and stronger genomic sequencing scale but is directly comparable in mandate, BSL-3 capacity, and role as a national reference center on the continent.
• Noguchi Memorial Institute for Medical Research: University of Ghana's flagship virology/immunology research institute performing national reference lab work for viral hemorrhagic fevers, influenza, and emerging pathogens in West Africa. It mirrors UVRI's role as a national reference lab, BSL operator, and African CDC partner, making it a close cross-regional peer.
• Centre Pasteur du Cameroun: Cameroon's Pasteur Institute branch operating as a national reference lab for viral diseases including arboviruses, HIV, and emerging pathogens in Central Africa. Comparable to UVRI as an African Pasteur-network member providing reference diagnostics, surveillance, and research capacity.

Broad incumbents

• Centers for Disease Control and Prevention (CDC): U.S. federal public health agency with global viral disease surveillance, reference laboratory, and outbreak response capabilities. CDC is a broad incumbent in the same category as UVRI but at far larger scale and scope, providing overlapping capabilities across diagnostics, genomics, and epidemiology.
• Africa CDC: Continental public health agency coordinating disease surveillance and outbreak response across African Union member states. Africa CDC sits above UVRI in the regional governance hierarchy and increasingly coordinates the network of national reference labs (including UVRI) for cross-border response.
• South African Medical Research Council (SAMRC): South Africa's statutory medical research council funding and conducting health research including infectious diseases. It overlaps with UVRI in mandate as a publicly funded health research institution but operates at broader scale and different funding mechanism.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/uvriug
• Facebookfacebook.com/UVRIug
• LinkedInlinkedin.com/company/uganda-virus-research-institute-ug

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uganda Virus Research Institute